Shenzhen-Made Medical Devices Sell In 191 Overseas Markets
This article was originally published in PharmAsia News
Executive SummaryShenzhen currently has 388 medical device producers selling products in 191 overseas markets, including the U.S., Japan and Germany, with an annual production of RMB 12 billion, according to the city's medical device association and industry insiders
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.